In vitro evaluation of the clinical utility of Apitolisib/Vorinostat combination in Apitolisib-resistant H1975 lung adenocarcinoma cells

Abduladim Hmmier(Center for Solar Energy Research and Studies), Paul Dowling(National University of Ireland, Maynooth)
Future Journal of Pharmaceutical Sciences
September 27, 2024
Cited by 2


Related Papers